Cristina Sensi

Department of Neuroscience, Psychology, Drug Research and Child Health University of Florence Florence Italy.

36 publications 2009 – 2026 ORCID

What does Cristina Sensi research?

Cristina Sensi studies gastric cancer, specifically how it spreads within the body and how this information can help tailor treatment for patients. By using a gene analysis method called cDNA-microarray, she investigates how certain genes behave differently in patients whose cancer has spread to lymph nodes compared to those whose cancer has not. This research is crucial because understanding the extent of cancer spread helps doctors determine the most appropriate and potentially aggressive treatment options for patients.

Key findings

  • In a study involving 29 gastric cancer patients, 12 specific genes were identified that showed different activity levels based on whether cancer had spread to lymph nodes.
  • The microarray analysis technique can potentially predict lymph node metastasis, assisting doctors in making more informed treatment decisions.
  • This research highlights the importance of gene behavior in assessing the aggressiveness of gastric cancer.

Frequently asked questions

Does Dr. Sensi study gastric cancer?
Yes, Dr. Sensi focuses primarily on gastric cancer and how it spreads within the body.
What treatments has Dr. Sensi researched?
Dr. Sensi's research helps guide treatment decisions for gastric cancer based on the likelihood of cancer spread to lymph nodes.
Is Dr. Sensi's work relevant to patients with gastric cancer?
Yes, her research is highly relevant as it aims to improve treatment strategies for patients with gastric cancer.

Publications in plain English

Refining Alzheimer's disease biological diagnosis with plasma biomarkers: Resolving p-tau217 "gray zone" with p-tau181 integration.

2026

Alzheimer's & dementia (Amsterdam, Netherlands)

Giacomucci G, Tabbì SMR, Ingannato A, Bagnoli S, Padiglioni S +9 more

Plain English
This study looked at ways to improve how we diagnose Alzheimer's disease using blood tests, focusing on two specific markers: p-tau217 and p-tau181. Researchers tested 401 people at different stages of Alzheimer's and found that the p-tau217 marker was very effective at distinguishing between those who are likely to have the disease and those who are not, achieving an accuracy rate of 94%. Importantly, when p-tau181 was included, it helped clarify results for 77.4% of patients who had unclear test results, which means we can better identify who truly has Alzheimer's. Who this helps: This benefits patients by providing more accurate and less invasive testing for Alzheimer's disease.

PubMed

Male breast cancer: a multicenter study to provide a guide for proper management.

2024

Breast cancer research and treatment

Lissidini G, Nicosia L, Sargenti M, Cucchi MC, Fabi A +17 more

Plain English
This study looked at the treatment and outcomes of male breast cancer by analyzing data from 403 patients over several decades in Italy. It found that 10 years after diagnosis, about 74% of men with invasive breast cancer were still alive, compared to 90% of men with non-invasive cases. Additionally, having more advanced cancer features, like a larger tumor size or higher grades, significantly increased the risk of death. Who this helps: This benefits male breast cancer patients by improving understanding of their disease and treatment options.

PubMed

The role of embodiment in the treatment of patients with anorexia and bulimia nervosa: a 2-year follow-up study proposing an integration between enhanced cognitive behavioural therapy and a phenomenological model of eating disorders.

2021

Eating and weight disorders : EWD

Rossi E, Castellini G, Cassioli E, Sensi C, Mancini M +2 more

Plain English
This study looked at how a treatment combination using enhanced cognitive behavioral therapy (CBT-E) and a focus on the concept of "embodiment" can help patients with anorexia and bulimia. Researchers followed 141 patients over two years and found that after one year, 44.7% of them showed significant improvement in their eating disorder symptoms, with many maintaining that progress over time. This is important because it shows that addressing the way patients experience their bodies can help them feel better and reduce eating disorder symptoms. Who this helps: This helps patients fighting anorexia and bulimia, as well as their healthcare providers.

PubMed

Lung Ultrasound Patterns and Clinical-Laboratory Correlates during COVID-19 Pneumonia: A Retrospective Study from North East Italy.

2021

Journal of clinical medicine

Senter R, Capone F, Pasqualin S, Cerruti L, Molinari L +29 more

Plain English
This study looked at how lung ultrasound (LUS) can help assess the severity and stage of COVID-19 pneumonia in hospitalized patients. Researchers analyzed 96 patients, finding that those with more severe disease had worse ultrasound patterns, particularly in the lower parts of their lungs. This matters because using LUS can provide valuable information on how severe someone’s COVID-19 pneumonia is, helping doctors monitor and treat patients more effectively. Who this helps: This helps doctors and healthcare providers manage care for COVID-19 patients.

PubMed

Higher Levels of C-Reactive Protein and Ferritin in Patients with Overweight and Obesity and SARS-CoV-2-Related Pneumonia.

2021

Obesity facts

Bettini S, Bucca G, Sensi C, Dal Prà C, Fabris R +2 more

Plain English
This study looked at how being overweight or obese affects the severity of COVID-19 in patients with pneumonia caused by the virus. Researchers found that 32.4% of overweight patients needed invasive mechanical ventilation compared to just 9% of normal-weight patients. Additionally, patients with obesity had higher levels of inflammation markers (CRP and ferritin) in their blood during their hospital stay, showing that excess weight contributes to more severe illness. Who this helps: This helps patients with COVID-19, particularly those who are overweight or obese.

PubMed

endocarditis in a low-risk woman: a case report.

2021

Clinical case reports

Gagliardi R, Sensi C, Flaminio G, De Canale E, Vettor R +1 more

Plain English
This study looks at a case of endocarditis, a serious heart infection, in a woman who was considered low-risk for the disease. The findings emphasize that early diagnosis and proper treatment are crucial to prevent severe complications. Understanding local disease patterns helps doctors decide which patients may need preventive antibiotics before certain medical procedures. Who this helps: This benefits patients and doctors by improving awareness and treatment of heart infections.

PubMed

Sexuality, embodiment and attachment style in anorexia nervosa.

2020

Eating and weight disorders : EWD

Cassioli E, Rossi E, Castellini G, Sensi C, Mancini M +4 more

Plain English
This study looked at how sexual dysfunctions relate to body awareness and attachment styles in women with anorexia nervosa. It found that 111 women with anorexia had worse scores in sexual desire and related areas compared to 120 healthy women. Specifically, those with anorexia who had low sexual desire also faced issues with their sense of body and attachment styles, indicating that eating disorders can significantly impact sexual health and intimacy. Who this helps: This research benefits patients with anorexia nervosa by highlighting the importance of addressing sexual health and emotional connections in their treatment.

PubMed

Pharmacological treatment of acute-phase anorexia nervosa: Evidence from randomized controlled trials.

2020

Journal of psychopharmacology (Oxford, England)

Cassioli E, Sensi C, Mannucci E, Ricca V, Rotella F

Plain English
This study looked at the effectiveness of medications for treating anorexia nervosa (AN) during its early phase. Researchers analyzed 19 clinical trials, focusing on how well these medications helped patients gain weight and improve mental health. They found that the drug olanzapine did not lead to significant weight recovery compared to placebo, and no medications showed benefits for worsening anxiety or depression symptoms. This is important because it highlights the lack of effective pharmacological treatments for a serious illness that has a very high mortality rate. Who this helps: This helps patients with anorexia nervosa and their healthcare providers by underscoring the need for better treatment options.

PubMed

Neural Correlates of Gender Face Perception in Transgender People.

2020

Journal of clinical medicine

Fisher AD, Ristori J, Castellini G, Cocchetti C, Cassioli E +11 more

Plain English
This study looked at how the brains of transgender people respond when they see faces of different genders. Researchers found that hormone-naïve transgender men showed increased brain activity in certain areas when distinguishing between female and male faces compared to cisgender women, while transgender women showed more activity in similar brain areas compared to cisgender men. These findings highlight a unique brain pattern related to gender dysphoria in transgender individuals, linking brain activity to feelings of discomfort with their bodies. Who this helps: This helps transgender individuals by increasing understanding of their experience and informing more effective care and support from healthcare professionals.

PubMed

Gender Dysphoria and Anorexia Nervosa Symptoms in Two Adolescents.

2019

Archives of sexual behavior

Ristori J, Fisher AD, Castellini G, Sensi C, Cipriani A +2 more

Plain English
This study looked at two teenagers who experienced both gender dysphoria and symptoms of anorexia nervosa, such as restricting food intake and a fear of gaining weight. After six months of treatment with a specific hormone therapy, both adolescents improved significantly, reporting healthier eating habits and no longer feeling the need to excessively exercise. This is important because it shows that the unhealthy eating behaviors might be a way to cope with the distress of gender dysphoria rather than a separate eating disorder, highlighting the need for proper assessment and early treatment options. Who this helps: This helps adolescents with gender dysphoria and eating disorders, as well as their mental health professionals.

PubMed

TargetingCPSF3 as a new approach to control toxoplasmosis.

2017

EMBO molecular medicine

Palencia A, Bougdour A, Brenier-Pinchart MP, Touquet B, Bertini RL +10 more

Plain English
This research studied a new treatment for toxoplasmosis, a serious illness that can affect people with weakened immune systems. The scientists found that a drug called AN3661 was very effective against the parasite causing the disease, with treated mice remaining healthy while untreated mice died from infection. This discovery highlights CPSF3 as a valuable target for developing new medications that could improve treatment options. Who this helps: Patients with toxoplasmosis, especially those with weakened immune systems.

PubMed

Psychological characteristics of Italian gender dysphoric adolescents: a case-control study.

2017

Journal of endocrinological investigation

Fisher AD, Ristori J, Castellini G, Sensi C, Cassioli E +6 more

Plain English
This study examined the mental health and well-being of 46 Italian adolescents with gender dysphoria compared to another group of 46 matched adolescents who do not experience gender dysphoria. The researchers found that those with gender dysphoria had much higher levels of body dissatisfaction and reported worse psychological functioning, including greater risks of depression and suicidal thoughts. Specifically, these adolescents demonstrated higher scores for anxiety, social problems, and a negative view of life, indicating significant distress and challenges in their daily lives. Who this helps: This research benefits adolescents with gender dysphoria and the healthcare professionals who support them.

PubMed

Identification of small molecules uncoupling the Notch::Jagged interaction through an integrated high-throughput screening.

2017

PloS one

Platonova N, Parravicini C, Sensi C, Paoli A, Colombo M +3 more

Plain English
This study explored how to block the interaction between two proteins, Notch and Jagged, which are involved in the growth and development of cells. Researchers used a series of tests to identify small molecules that can effectively disrupt this interaction and found two promising candidates that showed different levels of effectiveness in slowing down cancer cell growth in laboratory tests. This is important because it opens the door to creating new cancer treatments that target Notch signaling more directly, rather than relying on existing methods that affect multiple processes. Who this helps: This benefits cancer patients by paving the way for new, targeted therapies.

PubMed

Cross-Sex Hormone Treatment and Psychobiological Changes in Transsexual Persons: Two-Year Follow-Up Data.

2016

The Journal of clinical endocrinology and metabolism

Fisher AD, Castellini G, Ristori J, Casale H, Cassioli E +8 more

Plain English
This study looked at how hormone treatments for transgender individuals (known as cross-sex hormone treatment, or CHT) affect their mental well-being over two years. Researchers followed 54 people undergoing CHT and found that those who received the treatment reported significantly lower feelings of body discomfort, less depression, and overall better psychological health. Specifically, those who developed breasts during treatment felt better about their bodies, while those who gained weight also showed improved mental health. Who this helps: This benefits transgender patients undergoing hormone treatment.

PubMed

All-Purpose Containers? Lipid-Binding Protein - Drug Interactions.

2015

PloS one

Beringhelli T, Gianazza E, Maggioni D, Scanu S, Parravicini C +3 more

Plain English
This study looked at how certain proteins in the body, called calycins, interact with various drugs, especially steroids and cholesterol-lowering medications known as statins. It found that these proteins have a strong relationship with statins, particularly atorvastatin, which is one of the most common cholesterol medications. The strength of these interactions matters because it could affect how well drugs are delivered and absorbed in the body, influencing their overall effectiveness. Who this helps: This benefits patients who take statins and healthcare providers managing their treatment.

PubMed

Unfolding of beta-lactoglobulin on the surface of polystyrene nanoparticles: experimental and computational approaches.

2014

Proteins

Miriani M, Eberini I, Iametti S, Ferranti P, Sensi C +1 more

Plain English
This study looked at how a protein called beta-lactoglobulin (BLG) changes when it attaches to polystyrene nanoparticles. Researchers found that when BLG binds to these particles, its structure rearranges significantly, which increases its ability to trigger immune responses. Specifically, they noted that parts of the protein that were previously hidden become exposed, making it much more reactive. Who this helps: This information is useful for food scientists and manufacturers who work with proteins in food products.

PubMed

Nimesulide binding site in the B0AT1 (SLC6A19) amino acid transporter. Mechanism of inhibition revealed by proteoliposome transport assay and molecular modelling.

2014

Biochemical pharmacology

Pochini L, Seidita A, Sensi C, Scalise M, Eberini I +1 more

Plain English
This study looked at how different drugs affect the B0AT1 transporter in rat kidneys, focusing on how well they inhibit the transport of a specific amino acid called glutamine. The researchers found that most drugs didn’t have any impact, but the anti-inflammatory drug nimesulide was particularly effective, reducing transport by 88% at a concentration of 300 micromolar, with a half-maximal inhibitory concentration (IC50) of 23 micromolar. Understanding how nimesulide works can help in developing treatments for conditions related to amino acid transport disorders. Who this helps: This research benefits patients with amino acid transport issues and doctors treating related conditions.

PubMed

Distant homology modeling of LCAT and its validation through in silico targeting and in vitro and in vivo assays.

2014

PloS one

Sensi C, Simonelli S, Zanotti I, Tedeschi G, Lusardi G +3 more

Plain English
This study examined the structure and function of an enzyme called LCAT, which plays a crucial role in cholesterol metabolism. Researchers created a detailed model of LCAT using advanced technology and found that certain mutations near the enzyme's active site affected its activity. They also identified some compounds that can inhibit LCAT, which could impact treatments related to cholesterol levels. Who this helps: This helps patients with cholesterol-related issues and doctors looking for new treatment options.

PubMed

Recombinant S. cerevisiae expressing Old Yellow Enzymes from non-conventional yeasts: an easy system for selective reduction of activated alkenes.

2014

Microbial cell factories

Romano D, Contente ML, Molinari F, Eberini I, Ruvutuso E +4 more

Plain English
This study investigated a new method for using modified yeast cells to help produce specific chemical compounds more efficiently. The researchers found that these yeast cells could successfully reduce various compounds with double bonds, achieving high rates and selectivity in their reactions. For example, they tested different substances and noted that the yeast effectively reduced many of them, making it easier to create desired molecules without needing extra materials to support the reaction. Who this helps: This benefits chemists and researchers working in drug development and synthetic chemistry.

PubMed

In between - Proteomics of dog biological fluids.

2014

Journal of proteomics

Miller I, Preßlmayer-Hartler A, Wait R, Hummel K, Sensi C +3 more

Plain English
This study looks at the proteins found in the bodily fluids of dogs and how they relate to health and disease. Researchers gathered a lot of information about these proteins, including patterns observed in blood and urine from healthy and sick dogs. This is important because understanding these patterns can help with diagnosing and treating illnesses in dogs, as well as improving studies in human medicine. Who this helps: This helps veterinarians, researchers, and dog owners.

PubMed

A computational approach to evaluate the androgenic affinity of iprodione, procymidone, vinclozolin and their metabolites.

2014

PloS one

Galli CL, Sensi C, Fumagalli A, Parravicini C, Marinovich M +1 more

Plain English
This study looked at how certain chemicals (iprodione, procymidone, and vinclozolin), which can affect hormones, interact with the androgen receptor in humans, rats, and zebrafish. The researchers developed a computer-based method to measure how strongly these chemicals bind to the receptor, finding that rats were less sensitive to these substances compared to humans and zebrafish. This matters because understanding these interactions helps assess the risks of using these chemicals, guiding safer chemical evaluations without extensive animal testing. Who this helps: This helps patients and regulators in ensuring safer chemical products.

PubMed

Oxysterols act as promiscuous ligands of class-A GPCRs: in silico molecular modeling and in vitro validation.

2014

Cellular signalling

Sensi C, Daniele S, Parravicini C, Zappelli E, Russo V +4 more

Plain English
This study looked at how certain compounds called oxysterols can activate different receptors in the body, specifically a group known as GPCRs, which play important roles in immune responses and inflammation. Researchers discovered that oxysterols can interact with three receptors—EBI2, CXCR2, and GPR17—each in different ways, allowing them to influence various biological effects based on where and how much they are produced. Understanding this relationship is important because it could help explain how inflammation and oxidative stress are linked to diseases like cancer and neurodegenerative disorders. Who this helps: This benefits patients dealing with inflammatory conditions and doctors treating related diseases.

PubMed

cDNA-microarray analysis as a new tool to predict lymph node metastasis in gastric cancer.

2014

World journal of surgery

Ojetti V, Persiani R, Cananzi FC, Sensi C, Piscaglia AC +4 more

Plain English
This study looked at how a special gene analysis called microarray can help predict whether gastric cancer has spread to lymph nodes in patients. Researchers examined 29 patients and found that 12 specific genes behaved differently in patients with lymph node involvement compared to those without it. The findings indicate that this gene analysis could help doctors determine which patients may need more extensive treatment options based on their disease's severity. Who this helps: This helps patients with gastric cancer by guiding treatment decisions.

PubMed

Inflammatory serum proteome pattern in mice fed a high-fat diet.

2013

Amino acids

Gianazza E, Sensi C, Eberini I, Gilardi F, Giudici M +1 more

Plain English
Researchers studied how a high-fat diet affects protein levels in the blood of mice over eight weeks. They found that mice on this diet showed higher levels of specific proteins related to inflammation, including haptoglobin and hemopexin, indicating that the diet caused significant inflammation in the body. This matters because it helps us understand how a high-fat diet may lead to heart problems and other health issues in humans. Who this helps: This helps doctors and health professionals target dietary recommendations for preventing cardiovascular disease.

PubMed

A proteomic portrait of atherosclerosis.

2013

Journal of proteomics

Eberini I, Wait R, Calabresi L, Sensi C, Miller I +1 more

Plain English
This paper examined changes in proteins related to atherosclerosis, a condition that narrows arteries and can lead to heart disease. The researchers found that the size of lipoprotein particles and how proteins move through body fluids are important for understanding this disease, particularly in diagnosing chronic conditions using urine instead of blood samples. This matters because identifying how proteins behave can help in developing better diagnostic methods and treatments for atherosclerosis. Who this helps: This helps patients at risk of heart disease and doctors treating them.

PubMed

The oxysterol-CXCR2 axis plays a key role in the recruitment of tumor-promoting neutrophils.

2013

The Journal of experimental medicine

Raccosta L, Fontana R, Maggioni D, Lanterna C, Villablanca EJ +22 more

Plain English
This study looked at how certain molecules called oxysterols in tumors attract specific immune cells, known as neutrophils, that help tumors grow. Researchers found that these oxysterols specifically use a pathway called CXCR2 to bring in neutrophils, which then support tumor growth by helping form new blood vessels and dampening the immune system’s ability to fight the tumor. When they blocked this pathway, they saw that it slowed tumor growth and increased survival rates in mice with tumors. Who this helps: This helps cancer patients by identifying a new target for potential treatments.

PubMed

Electrostatics of folded and unfolded bovine β-lactoglobulin.

2012

Amino acids

Eberini I, Sensi C, Barbiroli A, Bonomi F, Iametti S +2 more

Plain English
This study looked at the behavior of a protein called beta-lactoglobulin from cows when it's folded and unfolded. Researchers found that the way the protein responds to a chemical called urea varies depending on the pH level, showing that certain parts of the protein change how they interact with their environment. Specifically, they discovered shifts in a specific part of the protein’s structure that can affect how it behaves at different pH levels, highlighting that the protein is more stable at lower pH. Who this helps: This research benefits scientists and researchers studying protein behavior and stability in various environments.

PubMed

Neglected markers: altered serum proteome in murine models of disease.

2012

Proteomics

Gianazza E, Vegeto E, Eberini I, Sensi C, Miller I

Plain English
This study examined the blood proteins of laboratory mice to better understand how changes in these proteins can indicate various diseases, especially cancer and metabolic disorders. The researchers discovered important shifts in the levels of certain proteins during illness, which may help in developing ways to screen and diagnose diseases in humans. By focusing on these protein changes, they aim to improve how we translate animal study findings to human healthcare. Who this helps: This benefits researchers and doctors who are working to diagnose and treat diseases in patients.

PubMed

Proteomics of rat biological fluids--the tenth anniversary update.

2012

Journal of proteomics

Gianazza E, Wait R, Eberini I, Sensi C, Sironi L +1 more

Plain English
This study reviewed ten years of research on the proteins found in various fluids from rats, like blood and urine, to understand how they change during illnesses and treatment. Researchers found significant differences in protein levels between healthy rats and those with inflammation, helping to track disease and treatment effects more accurately. It highlights a lack of consistent methods in past studies, which means important data might be overlooked or underreported. Who this helps: This benefits researchers and doctors working on disease treatments and diagnostics.

PubMed

Wards in the keyway: amino acids with anomalous pK(a)s in calycins.

2012

Amino acids

Eberini I, Sensi C, Bovi M, Molinari H, Galliano M +3 more

Plain English
This study looked at proteins called calycins, which are similar to a well-known protein called beta-lactoglobulin. Researchers found that certain amino acids in calycins can behave unusually when it comes to their chemical properties, specifically how they react to changes in acidity. In at least one case for each of the studied proteins, these unusual properties led to changes in the overall structure and function of the proteins, which is important for their roles in carrying substances and assisting in various biological processes. Who this helps: This research benefits scientists studying protein functions and developing treatments based on protein interactions.

PubMed

Energy matters: mitochondrial proteomics for biomedicine.

2011

Proteomics

Gianazza E, Eberini I, Sensi C, Barile M, Vergani L +1 more

Plain English
This paper looks at how studying proteins in mitochondria, the energy factories of our cells, can help in understanding diseases. Researchers found that different diseases, like genetic disorders or degenerative conditions, show unique patterns in mitochondrial proteins. This research is important because it can lead to better treatments tailored to specific diseases. Who this helps: Patients with genetic or degenerative diseases.

PubMed

Simulation of urea-induced protein unfolding: a lesson from bovine β-lactoglobulin.

2011

Journal of molecular graphics & modelling

Eberini I, Emerson A, Sensi C, Ragona L, Ricchiuto P +3 more

Plain English
Researchers studied how the protein bovine β-lactoglobulin (BLG) unfolds when exposed to urea and increased temperature. They found that urea weakens the protein's structure by disrupting key interactions, leading to changes in both its shape and stability. Specifically, raising the temperature to 350 K intensified these unfolding effects. Who this helps: This benefits scientists and researchers working on protein behavior and stability.

PubMed

In silico identification of new ligands for GPR17: a promising therapeutic target for neurodegenerative diseases.

2011

Journal of computer-aided molecular design

Eberini I, Daniele S, Parravicini C, Sensi C, Trincavelli ML +2 more

Plain English
The researchers aimed to find new compounds that could activate a receptor called GPR17, which might help treat neurodegenerative diseases. They screened over 130,000 different substances and successfully identified five new compounds that can activate this receptor more effectively than its natural activators. This discovery is significant as it opens up potential new treatments for conditions like Alzheimer's disease and Parkinson's disease. Who this helps: This helps patients with neurodegenerative diseases.

PubMed

Class A GPCRs: a multifaceted reality.

2011

Purinergic signalling

Parravicini C, Sensi C, Eberini I

PubMed

Structural and dynamic features of apolipoprotein A-I cysteine mutants, Milano and Paris, in synthetic HDL.

2010

Journal of molecular graphics & modelling

Rocco AG, Sensi C, Gianazza E, Calabresi L, Franceschini G +2 more

Plain English
Researchers studied two specific versions of a protein called apolipoprotein A-I, known as Milano and Paris, in a lab-created type of "good" cholesterol. They found that the Milano version breaks down faster than the normal version of the protein, with a degradation rate that was significantly higher, indicating it can be attacked more quickly by certain enzymes. Understanding the differences between these protein versions is important for figuring out how they affect heart health. Who this helps: This helps patients at risk of heart disease and doctors treating them.

PubMed

Structural features and dynamics properties of human apolipoprotein A-I in a model of synthetic HDL.

2009

Journal of molecular graphics & modelling

Rocco AG, Gianazza E, Calabresi L, Sensi C, Franceschini G +2 more

Plain English
This study examined the structure and behavior of a key protein called apolipoprotein A-I (apoA-I) found in high-density lipoproteins (HDL), which help transport cholesterol in the body. Researchers used computer simulations to understand how apoA-I interacts with lipids in synthetic HDL, revealing that specific movements between two apoA-I molecules help stabilize the structure and optimize interactions with lipids. These findings are important because they provide a clearer picture of how HDL works at a molecular level, which could lead to better treatments for cholesterol-related conditions. Who this helps: This helps patients at risk for heart disease and healthcare providers working to manage cholesterol levels.

PubMed

Publication data sourced from PubMed . Plain-English summaries generated by AI. Not medical advice.